These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29116280)

  • 1. The influence of the ancillary ligand on the potential of cobalt(iii) complexes to act as chaperones for hydroxamic acid-based drugs.
    Green BP; Renfrew AK; Glenister A; Turner P; Hambley TW
    Dalton Trans; 2017 Nov; 46(45):15897-15907. PubMed ID: 29116280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.
    Bonnitcha PD; Kim BJ; Hocking RK; Clegg JK; Turner P; Neville SM; Hambley TW
    Dalton Trans; 2012 Oct; 41(37):11293-304. PubMed ID: 22885674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses of 8-quinolinolatocobalt(III) complexes containing cyclen based auxiliary ligands as models for hypoxia-activated prodrugs.
    Chang JY; Stevenson RJ; Lu GL; Brothers PJ; Clark GR; Denny WA; Ware DC
    Dalton Trans; 2010 Dec; 39(48):11535-50. PubMed ID: 21103540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of hypoxia activated prodrugs: Co(III) complexes of hydroxamic acids.
    Failes TW; Hambley TW
    Dalton Trans; 2006 Apr; (15):1895-901. PubMed ID: 16585977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cobalt complexes with pyrazole ligands as catalyst precursors for the peroxidative oxidation of cyclohexane: X-ray absorption spectroscopy studies and biological applications.
    Silva TF; Martins LM; Guedes da Silva MF; Kuznetsov ML; Fernandes AR; Silva A; Pan CJ; Lee JF; Hwang BJ; Pombeiro AJ
    Chem Asian J; 2014 Apr; 9(4):1132-43. PubMed ID: 24482364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-bridged cyclen or cyclam Co(III) complexes containing cytotoxic ligands as hypoxia-activated prodrugs.
    Chang JY; Lu GL; Stevenson RJ; Brothers PJ; Clark GR; Botting KJ; Ferry DM; Tercel M; Wilson WR; Denny WA; Ware DC
    Inorg Chem; 2013 Jul; 52(13):7688-98. PubMed ID: 23773210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cobalt(III) hydroxamic acid complexes based on a tris(2-pyridylmethyl)amine scaffold: reactivity toward cysteine methyl ester.
    Alimi M; Allam A; Selkti M; Tomas A; Roussel P; Galardon E; Artaud I
    Inorg Chem; 2012 Sep; 51(17):9350-6. PubMed ID: 22905650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative, DNA binding, and cleavage properties of dinuclear Co(III) complexes containing the bioactive quinizarin ligand.
    Crlikova H; Kostrhunova H; Pracharova J; Kozsup M; Nagy S; Buglyó P; Brabec V; Kasparkova J
    J Biol Inorg Chem; 2020 Mar; 25(2):339-350. PubMed ID: 32112290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization and cytotoxicity studies of Co(III)-flavonolato complexes.
    Kozsup M; Zhou X; Farkas E; Bényei AC; Bonnet S; Patonay T; Kónya K; Buglyó P
    J Inorg Biochem; 2021 Apr; 217():111382. PubMed ID: 33588278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron(III) complexes of fluorescent hydroxamate ligands: preparation, properties, and cellular processing.
    Clarke AJ; Yamamoto N; Jensen P; Hambley TW
    Dalton Trans; 2009 Dec; (48):10787-98. PubMed ID: 20023908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of cobalt(iii)-triazole systems as prototypes for hypoxia-activated drug delivery.
    de Souza IC; Faro LV; Pinheiro CB; Gonzaga DT; da Silva Fde C; Ferreira VF; Miranda Fda S; Scarpellini M; Lanznaster M
    Dalton Trans; 2016 Sep; 45(35):13671-4. PubMed ID: 27488398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A series of mononuclear Co(III) complexes using tridentate N,O-donor ligands: chemical properties and cytotoxicity activity.
    Souza ET; Maia PJ; Azevedo EM; Kaiser CR; Resende JA; Pinheiro CB; Heinrich TA; da Silva RS; Scarpellini M
    J Inorg Biochem; 2011 Dec; 105(12):1767-73. PubMed ID: 22001498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. trans-Methylpyridine cyclen versus cross-bridged trans-methylpyridine cyclen. Synthesis, acid-base and metal complexation studies (metal = Co2+, Cu2+, and Zn2+).
    Bernier N; Costa J; Delgado R; Félix V; Royal G; Tripier R
    Dalton Trans; 2011 May; 40(17):4514-26. PubMed ID: 21409259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated Ir
    Martínez-Alonso M; Busto N; Aguirre LD; Berlanga L; Carrión MC; Cuevas JV; Rodríguez AM; Carbayo A; Manzano BR; Ortí E; Jalón FA; García B; Espino G
    Chemistry; 2018 Nov; 24(66):17523-17537. PubMed ID: 30176086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual targeting of hypoxic and acidic tumor environments with a cobalt(III) chaperone complex.
    Yamamoto N; Renfrew AK; Kim BJ; Bryce NS; Hambley TW
    J Med Chem; 2012 Dec; 55(24):11013-21. PubMed ID: 23199008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting curcumin to specific tumour cell environments: the influence of ancillary ligands.
    Glenister A; Chen CKJ; Tondl EM; Paterson D; Hambley TW; Renfrew AK
    Metallomics; 2017 Jun; 9(6):699-705. PubMed ID: 28488704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cobalt(II), nickel(II) and copper(II) complexes of a hexadentate pyridine amide ligand. Effect of donor atom (ether vs. thioether) on coordination geometry, spin-state of cobalt and M(III)-M(II) redox potential.
    Pandey S; Das PP; Singh AK; Mukherjee R
    Dalton Trans; 2011 Oct; 40(40):10758-68. PubMed ID: 21952226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetico-mechanistic studies of substitution reactions on cross-bridged cyclen Co(III) complexes with nucleosides and nucleotides.
    Vázquez M; Font-Bardia M; Martínez M
    Dalton Trans; 2015 Nov; 44(42):18643-55. PubMed ID: 26455445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cobalt(III) complexes as potential hypoxia-responsive carriers of esculetin.
    Palmeira-Mello MV; Caballero AB; Ribeiro JM; de Souza-Fagundes EM; Gamez P; Lanznaster M
    J Inorg Biochem; 2020 Oct; 211():111211. PubMed ID: 32805459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-Responsive Cobalt Complexes in Tumor Spheroids: Laser Ablation Inductively Coupled Plasma Mass Spectrometry and Magnetic Resonance Imaging Studies.
    O'Neill ES; Kaur A; Bishop DP; Shishmarev D; Kuchel PW; Grieve SM; Figtree GA; Renfrew AK; Bonnitcha PD; New EJ
    Inorg Chem; 2017 Aug; 56(16):9860-9868. PubMed ID: 28766939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.